Objective: To determine the prevalence of human papillomavirus (HPV) DNA in penile cancers in Rio de Janeiro, Brazil.
INTRODUCTION
Penile cancer prevalence varies according to geographic region and ethnic origin (1). In Brazil, penile cancer represents 2% of all cancers in males and is more frequent in north and northeast regions with an incidence ranging from 1.3 to 2.7 per 100,000, according to the geographic region (2) .
The mechanism by which Human Papillomavirus (HPV) leads to malignant transformation is likely Clinical Urology mediated through two viral genes, E6 and E7, which are actively transcribed in HPV infected cells. The E6 and E7 proteins bind to and inactivate the host cell's tumor suppressor gene products p53 and pRb, leading to uncontrolled growth. Although HPV genes have been detected in nearly 100% of cervical cancers, the presence of HPV infection in penile cancer is highly variable (3). HPV has been recognized as a possible etiological agent for penile carcinoma but its role in disease development and correlation to prognosis is still unclear.
HPV infections are associated with benign and malignant epithelial lesions and a high-risk HPV group is probably the major cause of anogenital cancers. To date, more than 100 HPV genotypes have data from 11 case-control studies from nine countries a high-risk group: 16 (4) .
The prevalence of HPV infections in penile cancer is similar to those observed in vulvar carciof penile cancer are consistently associated with HPV infection -basaloid and warty squamous cell carcinoma (3,5).
In Brazil, few studies have reported HPV infection in penile cancer. McCance et al. (6) showed a positivity of 49% using Southern blot for the detection of HPV DNA, while Bezerra et al. (7) reported a -bedded material using the polymerase chain reaction (PCR).
The aim of the present study was to assess the prevalence of HPV infection in a large series of patients with invasive squamous cell carcinoma and verrucous carcinoma of the penis.
Verrucous carcinoma is a less aggressive variant of squamous cell penile carcinoma, which rarely metastasizes to regional nodes regardless of size, evidence of local invasion or duration of disease (8) .
Invasive squamous cell carcinoma of the penis usually metastasizes to the inguinal region though lymphatic channels and approximately 20% of the patients whose nodes appear to be clinically normal have inguinal metastasis at operation.
MATERIALS AND METHODS

Histopathological Specimens
Eighty penile cancer specimens were collected from patients from three different Hospitals in Rio de Janeiro: Brazilian National Cancer Institute, Pedro Ernesto University Hospital and Mario Kröeff Cancer Hospital between March 1995 and June 2000. All patients were evaluated prospectively and gave their informed consent to participate in the study. Our Institutional Review Board also approved the study.
Specimen Processing and DNA Extraction
from the tumor region during surgical procedure and frozen at -80 o C or immediately processed. The specimens were washed in saline and cut into small pieces. Samples were then digested with 50 μL of proteinase K (10 mg/mL) in a volume of 3 mL of cell lyses solution (10 mM Tris-HCl pH 7.6, 10 mM EDTA pH 8.0 and 50 μL of SDS 10%) and incubated at 42 o C for 14 to 16 hours. DNA was recovered after ethanol precipitation, dried at room temperature and dissolved in sterile water. HeLa cell line DNA was used as an HPV positive control (9) . All samples were tested for PCR Reaction -cation using a generic pair of primers (MY09/MY11) for HPV (10) that amplify a fragment of the conserved reactions. DNA from a HeLa cell line infected with HPV-18, was used as a positive control. All positive 18. The expected PCR products were fragments of primers, respectively. Amplicons were analyzed by electrophoresis in a 1.5% agarose gel stained with positive for HPV DNA were genotyped by restriction fragment length polymorphism (RFLP). Specimens were examined without prior knowledge of the histology of the lesions. number of cycles was reduced to 30 and 2.5 μL of template was used (12) . Strict laboratory conditions were followed in order to avoid contamination.
Restriction Fragment Length Polymorphism Analysis
The amplicons obtained by the MY9/11 primer sets were submitted to RFLP using the enzymes BamHI, DdeI, HaeIII, RsaI and Sau3AI. The digested and non-digested PCR products were analyzed in 12% polyacrylamide gels. The gels were stained with ethidium bromide and photographed. Fragments were analyzed according to Bernard et al. (13) .
Clinicopathological Data
Specimens from 72 patients histologically diagnosed with invasive squamous cell carcinoma and specimens from 8 patients diagnosed with verrucous carcinoma were analyzed. Patients with verrucous penile carcinoma were studied to assess the prevalence of HPV infection. Patients with invasive squamous cell carcinoma of the penis were studied to assess the prevalence of HPV infection. Stage was based on of presentation according to the 1978 TNM system AJCC Cancer Staging Manual [AJCC, 2002] (14) . Patients were clinically observed during a median of (T1N0), II (T1N1,T2N0-1), III (T1N2,T2N2,T3N0-2) and IV (T1-3N3,T4N0-3).
The pathological material collected from patients with invasive squamous cell carcinoma was the Broder's grading system.
Statistical Analysis
Patient follow-up was gathered from medical charts from the Brazilian National Cancer Institute and when necessary through contact with the patient's family. The data obtained were recorded on standard performed using SPSS ® . Association with clinical stage, histopathological subtype and HPV status was done using the chi-square test. A "p" value < 0.05 actuarial survival rates was performed by the KaplanMeier method and log rank test. Differences were than 0.05.
RESULTS
A total of 80 specimens of penile tumors from an equal number of patients were analyzed. Patients were clinically observed during a median of 15 months (1 to 80 months). The mean age of patients was 57.6 years (ranging from 36 to 86 years) and no statistical difference was observed between HPV positive and negative patients.
The glans was the most frequent site in- HPV positive patients had better 5-year disease-free survival rates than those with negative HPV results although the differences between the 2 groups were not significant (p = 0.779, Figure- 2). The majority of penile cancer cases (40%)
node metastasis was associated with poor survival rate and no difference was observed in survival between HPV positive and HPV DNA negative cases.
Although the central role of HPV infection in the etiology of cervical cancer has been recognized, transformation in penile cancer. In addition, the presence of HPV DNA could not be considered a prognostic factor. Several epidemiological reports indicate that other factors such as the lack of circumcision, hygiene practices, the presence of other sexually transmitted diseases, the number of sexual partners and cigarette smoking may predispose to penile carcinogenesis, and the exact role of HPV infection in the development of penile cancers remains to be elucidated.
On June 8, 2006 , the U.S. Food and Drug Administration approved the use of a new vaccine to prevent infection from four types of HPV. Two of the HPV types targeted by the vaccine (HPV-16 and HPV-18) are responsible for about 70 percent of the cases of cervical cancer worldwide. The other two HPV types (HPV-6 and HPV-11) cause approximately 90 percent of the cases of genital warts. The vaccine is currently recommended for use in young females before they become sexually active, and its possible use in males is under scrutiny. One of several reasons that HPV vaccines have focused on women rather than men is that cervical cancer accounts for 80 percent of HPV-related cancers. Male cancers are obviously in the minority, the prevalence of HPV infection. While women have about 80 percent of the total burden of disease and death, it is certainly not inconsequential for men. Penile cancer affects 100,000 men a year worldwide, and the numbers are increasing. As a global issue, penile cancer is a relevant problem. For heterosexual men, the main genital warts and, potentially, cervicalcancer in women. While studies have not yet been carried out, the hope is that the vaccine may eventually help prevent cancers linked to HPV, including penile cancers. If the vaccine proves successful, the administration of HPV vaccines could eventually become a requirement for boys and girls in middle school or high schoolas a potential way to reduce HPV infection (23).
Improved sampling techniques of the male genitalia and cohort studies in progress should provide important information on the natural history of HPV infection and disease in men, including risk factors for HPV acquisition and transmission. The impact on HPV infection in males of the vaccination in women will also need to be assessed.
EDITORIAL COMMENT
This study is very welcome as it demonstrates the high rate of human papillomavirus (HPV) associated with penile cancer. The detection rate of 75% approaches the rate of 90% seen in carcinoma in-situ. Other studies show lower HPV rates. It was unclear if this was due to differences in technique, such as immunohistochemistry or due to real variations in biology. Furthermore, the lower rate of HPV (50%) in verrucous type indicates a possible different etiology to this subset of cancer. Studying the subtypes of HPV associated with penile cancer is paramount currently, given the recent development of vaccines the effect mass vaccination of females will have on males, but ought to reduce carriage of HPV among heterosexual males. Vaccinating males may have the whole female population is unlikely. Reducing the overall population pool of these subtypes is on the incidence and type of penile cancer is likely have a lead time of several decades, as only a quarter of men with penile cancer present under the age of 50. Projections must also take into account the increasing life-expectancies in developed countries with more men living into their 70s and 80s, where the disease is more prevalent (see http:// www.oecd. org/statsportal/). Thus in the absence of any vaccination the prevalence is likely to increase, whereas even with successful vaccination changes in demographics subtypes of HPV being targeted may result in only some cancers being prevented. These factors must be brought together in modeling and scenario planning when formulating strategies for service provision in any healthcare system.
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EDITORIAL COMMENT
The prevalence of penile cancer in Brazil is 2% and this is higher than in the USA and Europe, where it accounts for 0.3 to 0.6% of cancers (1,2). Squamous cell carcinoma (SCC) is the most common histological type of penile cancer and represents 95% of cases. However the aetiology of penile cancer is unknown, risk factors include age and lack of circumcision (1,2). Other predisposing factors to the development of penile SCC are the chronic inflammatory disorder penile lichen sclerosus (LS) (also termed balanitis xerotica obliterans) (3-6) or human papillomavirus (HPV) infection (1, 2, 7, 8) . A common aetiology for penile and cervical cancer is suggested by the geographical correlation between the incidence of penile and cervical cancers worldwide (9) . The persistent infection with sexually transmitted high risk HPV is the main cause of cervical cancer (10, 11) . The prevalence of HPV penile infections in healthy men is reported to be 39% in Brazil and 3-9% in Western Europe, where there is a lower incidence of penile cancer (12, 13) . However, HPV detection in penile cancer cases varies from 20-80%, depending on detection method and geographical location (1,2). This is unlike cervical cancer where HPV infection can be detected in almost all cases (10) .
The paper entitled "Human Papillomavirus and Penile Cancers in Rio de Janeiro, Brazil: HPV Typing and Clinical Features" concerns penile cancer HPV infection and survival in 80 consecutive cases of patients who underwent surgery at Hospitals in Rio de Janeiro between 1995 and 2000. High risk HPV 16 was the predominate HPV type detected and no correlation was observed between HPV status (all types) and penile cancer subtype, stage, regional metastases or survival. HPV 16 has previously been reported to predominate in penile lichen sclerosus and SCC and may be an aetiological agent penile cancers (7, 14) . However the importance of HPV status in penile cancer progression and patient survival is controversial, as high-risk HPV is associated with aggressive variants (8) but recent series examining the relationship of HPV infection with prognosis have revealed either no correlation survival or a favourable survival (15, 16) . This study from Rio de Janeiro is consistent with only inguinal metastasis being a prognostic factor for penile cancer survival. In summary, high risk HPV infection occurs in penile SCC and it is likely to be an aeproportion of penile cancers. These results are important as prophylactic HPV vaccines for prevention of cervical cancer in women could also prevent penile cancers in men. However, several studies, including this one, show that once penile cancer has developed poor prognosis is associated with the occurrence of lymph node metastasis and not HPV status.
